Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-1024x341.jpg)
![](https://www.copanusa.com/wp-content/uploads/2021/12/iStock-1206219776-1170x658-1-640x360.jpg)
COPAN Resolves U.S.I.T.C. Unfair Competition Investigation with Several Manufacturers and Distributors of Imported Flocked Swabs
December 21, 2021
![](https://www.copanusa.com/wp-content/uploads/2021/09/COPAN-UTM-foam-minitip-swabs2-970x776-1-640x512.jpg)
U.S.I.T.C Institutes Unfair Competition Investigation of Imported Flocked Swabs and Kits
September 17, 2021
![](https://www.copanusa.com/wp-content/uploads/2021/04/iStock-1279773766-1170x780-1-640x427.jpg)
COPAN UniVerse™ Facilitates Newly Announced Streamlined Approach for Pooled Serial Screening Testing Programs
April 21, 2021
![](https://www.copanusa.com/wp-content/uploads/2024/01/universe.jpg)
COPAN Diagnostics’ Announces its North American Launch of UniVerse™, COPAN’s Fully Automated Instrument for Molecular Specimen Preparation prior to Testing
April 19, 2021
![](https://www.copanusa.com/wp-content/uploads/2021/01/Produzione_UTM_Copan_3-500x333-1.jpeg)
COPAN Group’s Response to the Pandemic and our Efforts to Fight COVID-19 Worldwide
January 29, 2021